CoorsTek Medical announced a five-year, multi-million dollar capital investment program to support the growing worldwide demand for its ceramic hip replacement components and turn-key hip arthroplasty solutions.
The investment funds a twenty-fold production expansion of these products as major medical device manufacturers adopt the company’s CeraSurf medical-grade ceramics.
The CoorsTek Medical CeraSurf alumina matrix composite is both CE-compliant and substantially equivalent to the latest generation material used in ceramic hip implants today.
Since 2011 more than 7,000 CeraSurf hip balls and acetabular liners have been sold for distribution across key global markets
As the largest manufacturer of engineered ceramics, CoorsTek produces critical-duty products and components for 10,000 customers from its portfolio of more than 300 advanced materials.
CoorsTek Medical provides specialized OEM medical device solutions designed around durable, biocompatible ceramic technology – delivering more than 1,000,000 components annually to the world’s leading medical device manufacturers.
"As we engage medical innovators and key opinion leaders globally, they are applying the unique, high performance benefits of our ceramic materials to improve the longevity and lifestyle for more patients each year," explains Jonathan Coors, CEO of CoorsTek Medical.
"Our valued partners deserve a choice and will be successful with a trusted partner who embraces today’s dynamic healthcare economy. This investment demonstrates the CoorsTek Medical commitment to being that partner of choice for implant-grade ceramic materials which make lives measurably better."
CoorsTek Medical offers the specialized knowledge, experience, world-class infrastructure and proven processes required to get medical device innovations to market quickly and successfully.